- Home
- ORGO vs VCV Comparison
ORGO vs VCV Comparison
Compare ORGO & VCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- VCV
- Stock Information
- Founded
- ORGO 1985
- VCV 1993
- Country
- ORGO United States
- VCV United States
- Employees
- ORGO N/A
- VCV N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- VCV Trusts Except Educational Religious and Charitable
- Sector
- ORGO Health Care
- VCV Finance
- Exchange
- ORGO Nasdaq
- VCV Nasdaq
- Market Cap
- ORGO 465.6M
- VCV 491.4M
- IPO Year
- ORGO N/A
- VCV N/A
- Fundamental
- Price
- ORGO $4.32
- VCV $10.50
- Analyst Decision
- ORGO Hold
- VCV
- Analyst Count
- ORGO 1
- VCV 0
- Target Price
- ORGO $6.00
- VCV N/A
- AVG Volume (30 Days)
- ORGO 918.2K
- VCV 107.9K
- Earning Date
- ORGO 08-07-2025
- VCV 01-01-0001
- Dividend Yield
- ORGO N/A
- VCV 4.09%
- EPS Growth
- ORGO N/A
- VCV N/A
- EPS
- ORGO N/A
- VCV 0.13
- Revenue
- ORGO $458,760,000.00
- VCV N/A
- Revenue This Year
- ORGO $1.10
- VCV N/A
- Revenue Next Year
- ORGO $9.93
- VCV N/A
- P/E Ratio
- ORGO N/A
- VCV $75.82
- Revenue Growth
- ORGO 5.35
- VCV N/A
- 52 Week Low
- ORGO $2.28
- VCV $8.05
- 52 Week High
- ORGO $6.71
- VCV $10.40
- Technical
- Relative Strength Index (RSI)
- ORGO 68.34
- VCV 62.72
- Support Level
- ORGO $3.59
- VCV $10.39
- Resistance Level
- ORGO $4.70
- VCV $10.57
- Average True Range (ATR)
- ORGO 0.23
- VCV 0.12
- MACD
- ORGO 0.12
- VCV 0.03
- Stochastic Oscillator
- ORGO 81.15
- VCV 69.63
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About VCV Invesco California Value Municipal Income Trust
Invesco California Value Municipal Income Trust is engaged in the field of financial services. Its objective is to seek to provide common shareholders with a high level of current income exempt from federal and California income taxes, consistent with preservation of capital.